Proprio

Seattle, United States Founded: 2016 • Age: 10 yrs
Visualization systems for surgical procedures are developed using machine learning.

About Proprio

Proprio is a Healthcare company based in Seattle (United States) founded in 2016 by Gabriel Jones. Visualization systems for surgical procedures are developed using machine learning. Proprio has raised $74.25 million across 4 funding rounds from investors including Bird B, DCVC and Cota Capital. The company has 52 employees. Its chief executive, as recorded, is Gabriel Jones. Proprio offers products and services including Proprio Platform. Its focus areas include Life Sciences, Surgical Instruments and Navigation Systems. Its legal entity is PROPRIO, INC. Its competitors include ClearPoint Neuro, IMRIS Deerfield Imaging and Centerline Biomedical; 2 of its 3 listed competitors have raised funding.

Company details

Proprio was founded in 2016 in Seattle, United States, focusing on medical technology. A multicamera system is utilized, incorporating machine learning, computer graphics processing, and specialized hardware to generate 3D videos and images of surgical sites. These tools support training programs and navigation during operations, enhancing precision in healthcare settings.

  • Headquarters Seattle, United States
  • Employees 52
  • Founders Gabriel Jones
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website propriovision.com
  • Social LinkedIn X
  • Legal Name Proprio, Inc
Key Metrics
  • Total Equity Funding
    $74.25M (USD)

    in 4 rounds

  • Latest Funding Round
    $43M (USD), Series B

    Jul 2023

  • Investors
    Bird B.

    & 4 more

  • Employee Count
    52

Products & Services of Proprio

Proprio offers a comprehensive portfolio of products and services, including Proprio Platform.

Proprio Platform
Surgical Technology

Platform for real-time data intelligence in surgical procedures.

Funding Insights of Proprio

Proprio has successfully raised a total of $74.25M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $43 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $74.25M
  • Total Rounds 4
  • Last Round Series B β€” $43M
  • First Round $1.25M

    (Jul 2017)

  • Investors Count 5

All 4 funding rounds of Proprio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2023$43MSeries B––
Jun 2020$23MSeries A–DCVC
Jan 2019$7MSeries A––
–
Jul 2017$1.25MSeed––
–
Valuation history

5 investors in total: 4 institutional and 1 angel.

Investors in Proprio

Proprio has secured backing from 5 investors, including venture fund and angel investors. Prominent investors backing the company include Bird B, DCVC and Cota Capital.

All
Venture Fund
Angel
InvestorDescriptionFounded YearDomainLocation
Bird B. AG is engaged in medical technology investments.
2003bird-b.comSchaffhausen, Switzerland
Venture capital firm focused on multiple sectors
dcvc.comPalo Alto, United States
Stage-agnostic venture capital investments are focused on US sectors.
cotacapital.comSan Francisco, United States
Early-stage life sciences and tech focused VC firm investing primarily in the US
boldcapitalpartners.comSanta Monica, United States

Alan Frazier

unknown_067c03dc6fa84167a
Premium access

Investor details for Proprio

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Proprio

45 people are tracked at Proprio (11 in leadership, 16 in board & advisors, 18 in team); the tracked headcount is 52.

NameRoleGroup
Gabriel Jones
Co-Founder & CEOLeadership
Sharif Razzaque
VP Of EngineeringLeadership
Bryan Humbarger
Chief Commercial OfficerLeadership
Tommy C.
Vice President, Product Management And MarketingLeadership
James Youngquist
Co-Founder & Head, Research & DevelopmentLeadership
Jason Schoen
Director Of Product DevelopmentLeadership
Ray Calvert
CFO & VP, OperationsLeadership
Thomas Nonn
Director Of Computational ImagingLeadership
Robert Grupp
Director Of Algorithms EngineeringLeadership
David Fiorella
Director Of Marketing, UpstreamLeadership
Michael Levitt
Director, Clinical OperationsLeadership
Rajiv Saigal
AdvisorBoard & advisors
Desney Tan
AdvisorBoard & advisors
Takeo Kanade
AdvisorBoard & advisors
Charles Fisher
AdvisorBoard & advisors
Alan Levy
Board MemberBoard & advisors
Gordon Wetzstein
AdvisorBoard & advisors
Kenneth Denman
Co-Founder & Chairman, Board of DirectorsBoard & advisors
Alan Cohen
Board MemberBoard & advisors
Joshua Smith
Co-Founder & AdvisorBoard & advisors

25 more people are available in the full profile.

Premium access

Complete people profiles for Proprio

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Proprio

3 dated milestones of Proprio across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Proprio is founded.
  2. Funding First funding round of $1.2M.
  3. Funding Latest funding round, Series B, of $43.0M.

Competitors of Proprio

Proprio has 3 listed competitors in our database, 2 of them funded. They include ClearPoint Neuro, IMRIS Deerfield Imaging and Centerline Biomedical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
clearpointneuro.com1998Irvine, United States$17.04M38
Software and hardware solutions for MRI-guided surgical planning are provided.
imris.com2005Minnetonka, United States100
Surgical theatres with ceiling mounted mobile imaging devices to enhance intraoperative workflow
centerlinebiomedical.com2014Cleveland, United States$76.26M
Developer of surgical navigation and image guidance system for endovascular procedures
Premium access

Detailed competitors of Proprio

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Proprio

The website of Proprio (propriovision.com) receives about 4.1K visits a month.

  • Monthly visits
    4.1K

    ▲ 19.7% vs previous month

Top companies in Medical Equipment & Supplies

3 companies that operate in the same segment as Proprio (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Robotic waterjet system for prostate tissue removal is developed.
2009Redwood City, California, United StatesUSD 348.84 MUSD 308.05 M756
Robotic microsurgical systems for endoscopy are developed.
2007Redwood City, California, United StatesUSD 733.62 M91
Injectable packaging, containment, and delivery solutions are manufactured.
1923Exton, Pennsylvania, United StatesUSD 3.07 B10,600
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Proprio

Premium access

Complete news archive for Proprio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Proprio

Proprio was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Proprio is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.

Gabriel Jones is the CEO of Proprio, as recorded in our data. They have also founded this company.

Proprio is a funded company, having raised a total of $74.25M across 4 funding rounds to date. The company's 1st funding round was a Seed of $1.25M, raised on Jul 2017.

Proprio has 52 employees.

Proprio was founded in 2016 in Seattle, United States, focusing on medical technology. A multicamera system is utilized, incorporating machine learning, computer graphics processing, and specialized hardware to generate 3D videos and images of surgical sites. These tools support training programs and navigation during operations, enhancing precision in healthcare settings.

Proprio's top competitors include ClearPoint Neuro, Centerline Biomedical and IMRIS Deerfield Imaging.

Proprio offers Proprio Platform.

Proprio has 5 investors. Key investors include Bird B, DCVC, Cota Capital, Bold Capital Partners, and Alan Frazier.

Proprio operates through Proprio, Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available